Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet

Background: There have been no studies of dual administration of sublingual immunotherapy (SLIT) tablets for perennial and seasonal allergic rhinitis. This trial (JapicCTI-184014) was conducted to investigate the safety profile and immunological response during dual therapy with SQ house dust mite (...

Full description

Bibliographic Details
Main Authors:	Minoru Gotoh, Kimihiro Okubo, Atsushi Yuta, Yukiko Ogawa, Hitoshi Nagakura, Shigehiro Ueyama, Tomoyo Ueyama, Kayoko Kawashima, Masashi Yamamoto, Shigeharu Fujieda, Masafumi Sakashita, Hirokazu Sakamoto, Naruhito Iwasaki, Eri Mori, Tomonori Endo, Nobuo Ohta, Hiroshi Kitazawa, Mitsuhiro Okano, Mikiya Asako, Masami Takada, Tetsuya Terada, Yuko Inaka, Syuji Yonekura, Tomokazu Matsuoka, Shinya Kaneko, Hiroki Hata, Nagisa Hijikata, Hisataka Tanaka, Keisuke Masuyama, Yoshitaka Okamoto
Format:	Article
Language:	English
Published:	Elsevier 2020-01-01
Series:	Allergology International
Online Access:	http://www.sciencedirect.com/science/article/pii/S132389301930108X

Similar Items

Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis
by: Tomoya Kurokawa, MD, PhD, et al.
Published: (2023-05-01)

A Randomized Double-Blind Comparative Study of Sublingual Immunotherapy for Cedar Pollinosis
by: Kimihiro Okubo, et al.
Published: (2008-01-01)

Sublingual Immunotherapy for Japanese Cedar Pollinosis
by: Minoru Gotoh, et al.
Published: (2005-01-01)

Sublingual Immunotherapy for Japanese Cedar Pollinosis
by: Kimihiro Okubo, et al.
Published: (2009-01-01)

Japanese cedar pollen sublingual immunotherapy is effective in treating seasonal allergic rhinitis during the pollen dispersal period for Japanese cedar and Japanese cypress
by: Syuji Yonekura, et al.
Published: (2022-01-01)

An analysis of factors related to the effect of sublingual immunotherapy on Japanese cedar pollen induced allergic rhinitis
by: Syuji Yonekura, et al.
Published: (2018-04-01)

Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons
by: Syuji Yonekura, et al.
Published: (2019-10-01)

The Preparation and Evaluation of Cyanocobalamin Mucoadhesive Sublingual Tablets
by: Anwar Ma’ali, et al.
Published: (2023-10-01)

Complement Factor H Is an Early Predictive Biomarker of the Therapeutic Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis
by: Riyo Yoneda, et al.
Published: (2022-11-01)

Preparation and Evaluation of Telmisartan Solid Dispersion as Sublingual Tablets
by: Hiba Ayad Aziz, et al.
Published: (2024-01-01)

Anti-IgE Antibody Therapy for Japanese Cedar Pollinosis: Omalizumab Update
by: Kimihiro Okubo, et al.
Published: (2008-01-01)

Decreased numbers of metachromatic cells in nasal swabs in Japanese cedar pollinosis following sublingual immunotherapy
by: Kuninori Otsuka, et al.
Published: (2020-09-01)

Preference for sublingual immunotherapy with tablets in a Spanish population with allergic rhinitis
by: Mette Bøgelund, et al.
Published: (2022-02-01)

Carbonic acid tablets promote submandibular-sublingual salivary secretion in humans
by: Kenkichi Yamamoto, et al.
Published: (2020-11-01)

Formulation of sublingual promethazine hydrochloride tablets for rapid relief of motion sickness
by: Hamad S Alyami, et al.
Published: (2021-05-01)

Enhancing Sublingual Tablet Quality through QbD: Current Trends and Insights"
by: Deepak Joshi, et al.
Published: (2023-09-01)

Present Situation of Cedar Pollinosis in Japan and its Immune Responses
by: Yoshitaka Okamoto, et al.
Published: (2009-01-01)

Omalizumab is Effective and Safe in the Treatment of Japanese Cedar Pollen-induced Seasonal Allergic Rhinitis
by: Kimihiro Okubo, et al.
Published: (2006-01-01)

Preclinical Safety and Pharmacokinetics of Heat Stable Oxytocin in Sublingual Fast-Dissolving Tablet Formulation
by: Changcheng Zhu, et al.
Published: (2022-04-01)

Sufentanil Sublingual Tablet Reduces Postoperative Opioid Use Following Outpatient Plastic Surgery
by: Hisham Seify
Published: (2022-05-01)

Worldwide surveys on anaphylaxis to sublingual immunotherapy with house dust mite tablets are urgently needed
by: Ralph Mösges, et al.
Published: (2021-03-01)

Tableting of mini-tablets in comparison with conventionally sized tablets: A comparison of tableting properties and tablet dimensions
by: Ard Lura, et al.
Published: (2020-12-01)

Inhibition of the Antigen Provoked Nasal Reaction by Second-generation Antihistamines in Patients with Japanese Cedar Pollinosis
by: Kimihiro Okubo, et al.
Published: (2006-01-01)

Evaluation of sufentanil sublingual tablet 30 mcg for perioperative pain management of in-office rhinology procedures
by: Ashley Sikand, et al.
Published: (2023-06-01)

Efficacy of a house dust mite sublingual immunotherapy tablet as add-on dupilumab in asthma with rhinitis
by: Makoto Hoshino, et al.
Published: (2022-10-01)

Awake Plastic Surgery Procedures: The Use of a Sufentanil Sublingual Tablet to Improve Patient Experience
by: Hisham Seify
Published: (2022-01-01)

Allergen Release Profiles of Fast-Dissolving Freeze-Dried Orodispersible Sublingual Allergy Immunotherapy Tablets
by: Takashi Yamamoto, PhD, et al.
Published: (2022-01-01)

Sublingual Immunotherapy for Japanese Cedar Pollinosis: Current Clinical and Research Status
by: Daiju Sakurai, et al.
Published: (2022-11-01)

Effect of Japanese Cedar Pollen Sublingual Immunotherapy on Asthma Patients with Seasonal Allergic Rhinitis Caused by Japanese Cedar Pollen
by: Shoko Ueda, et al.
Published: (2022-03-01)

Review on Tablet in Tablet techniques
by: Sachin S. Gaikwad, et al.
Published: (2020-01-01)

Delay of Onset of Symptoms of Japanese Cedar Pollinosis by Treatment with a Leukotriene Receptor Antagonist
by: Minoru Gotoh, et al.
Published: (2011-01-01)

House dust mite sublingual allergen immunotherapy tablet is safe and well-tolerated in Dutch clinical practice
by: Žana Tempels-Pavlica, et al.
Published: (2024-02-01)

Formulation Development of Sublingual Cyclobenzaprine Tablets Empowered by Standardized and Physiologically Relevant Ex Vivo Permeation Studies
by: Haidara Majid, et al.
Published: (2021-09-01)

Commentary on: Awake Plastic Surgery Procedures: The Use of a Sufentanil Sublingual Tablet to Improve Patient Experience
by: Mikaela L Kislevitz, et al.
Published: (2022-02-01)

Randomized controlled trial of ragweed sublingual immunotherapy tablet in the subpopulation of Canadian children and adolescents with allergic rhinoconjunctivitis
by: Anne K. Ellis, et al.
Published: (2021-12-01)

Novel sublingual tablets of Atorvastatin calcium/Trimetazidine hydrochloride combination; HPTLC quantification, in vitro formulation and characterization
by: Noha N. Atia, et al.
Published: (2019-05-01)

Sufentanil sublingual tablet system (Zalviso®) as an effective analgesic option after thoracic surgery: An observational study
by: Costa Fabio, et al.
Published: (2019-01-01)

Satisfaction and quality of life of allergic patients following sublingual five-grass pollen tablet immunotherapy in Spain
by: Darío Antolín-Amerigo, et al.
Published: (2017-11-01)

Improvement of Resveratrol Permeation through Sublingual Mucosa: Chemical Permeation Enhancers versus Spray Drying Technique to Obtain Fast-Disintegrating Sublingual Mini-Tablets
by: Giulia Di Prima, et al.
Published: (2021-08-01)

Investigating Japanese cedar pollen-induced allergic rhinitis and related terms using Google Trends
by: Tomohisa Iinuma, et al.
Published: (2020-10-01)